Last Updated on December 31, 2023 by The Health Master
The Drugs Controller General of India (DCGI) has approved three C-19 vaccines for children who are aged above five years.
The health regulator has given the Emergency Use Authorisation (EUA) to ZyCoV-D by Zydus Lifesciences, which is a two-dose vaccine. It will be administered to those aged 12 years and above.
Apart from it, the DCGI has also approved Covaxin manufactured by Bharat Biotech and Corbevax by Biological E.
While Covaxin has been approved for children aged between six and 12 years, Corbevax has got the approval for those who belong to the five-to-12-year age group.
Govt approves 16 applications under PLI schemes for APIs & Medical Devices
NPPA fixes retail price of 302 new drugs in fiscal year 2021-22
Aurobindo, Sun Pharma recall products due to these reasons
IPGA Haryana organized a seminar to share knowledge for Pharma sector
Drug recall: Pfizer recalls some batches of Blood Pressure drug due…
NPPA panel rejects Cadila Healthcare’s application to fix retail price of…
SEC of DCGI asked Bharat Biotech to provide more data on Covaxin for children aged below 12
Govt working on policy to boost R&D in Pharma Sector
USFDA gives tentative nod to Alembic Pharma for Ivabradine tablets
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
